Accelerated weight loss with feeling full and appetite control. Ask us Today.

Semaglutide is a Glucagon-like peptide-1 (GLP-1) produced by the gut. It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion, which is a hormone that raises blood sugar, reduces appetite and energy intake while delaying gastric emptying.

It was first developed in 2012 by Novo Nordisk as a longer-acting option to Liraglutide. In 2017 this drug was approved as an anti-diabetic medication used to treat type 2 diabetes and obesity.

How It Works

How It Works

  • Reduces food intake by lowering appetite
  • Slows food digestion in the stomach
  • Decrease body fat percentage
  • Help Weight loss
  • Decreased cardiovascular outcomes in subjects with type 2 diabetes and cardiovascular disease L
  • Lower HbA1c levels. Enhance the growth of β cells in the pancreas
  • FDA Approved